Target intelligence / Profile preview

U6 small nuclear RNA 142, pseudogene (RNU6-142P)

Target
RNU6-142P
Molecular classification
Other
01

Overview

**RNU6-142P** refers to a *pseudogene* of U6 small nuclear RNA (snRNA). The canonical U6 snRNA is a highly conserved, abundant noncoding RNA component of the spliceosome, playing a critical role in pre-mRNA splicing by assembling at the heart of the spliceosome’s active site and coordinating the chemistry of intron removal[1][2]. However, pseudogenes such as RNU6-142P are nonfunctional genomic DNA sequences that resemble functional snRNA genes but are generally not transcribed or, if transcribed, do not participate in the canonical spliceosomal activity[3]. These pseudogenes may arise through genome duplication or retrotransposition events over evolutionary time, and while they sometimes play regulatory regulatory roles, most have no known biological function[3]. RNU6-142P is therefore not considered a therapeutic target, a receptor, or an enzyme.\n\n**Key context:**\n- The **U6 snRNA** is essential for splicing, but this entry refers specifically to a *pseudogene*, meaning it is a nonfunctional copy[1][2][3].\n- There is no evidence that **RNU6-142P** acts as a receptor, enzyme, transporter, or any other classical drug target class.\n- The molecule is generally not part of any disease mechanism, is not a biomarker, and is not targeted by any drugs.\n- Pseudogenes like RNU6-142P may serve as genetic markers in some genomic studies but do not have established roles in human biology or therapeutics[3].\n\nIf you require information on the active, functional U6 snRNA (not a pseudogene), please clarify.

Other names
RNU6-142PRNA, U6 small nuclear 142, pseudogeneU6 snRNA pseudogene 142

Beyond the preview

Go deeper on U6 small nuclear RNA 142, pseudogene (RNU6-142P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U6 small nuclear RNA 142, pseudogene (RNU6-142P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call